Project Grant R25CA306811
- The National Cancer Institute awarded Wake Forest University Health Sciences $323,623 on June 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to deliver the Qualitative Training Institute for Enhancing Cancer Research (CANCERQTI), a six-month hybrid skills development program addressing qualitative research methods in oncology. CANCERQTI recruits and enrolls 25 oncology researchers annually into a curriculum grounded in Kolb's experiential learning theory, designed to build...
- The National Cancer Institute awarded $269,597 to the Beckman Research Institute of The City of Hope on August 10, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver clinical trials nursing education. The recipient will create a curriculum to train oncology clinical trials nurses in quality care for patients enrolled in cancer treatment trials, deliver the curriculum through five national in-person courses and virtual offerings to competitively selected...
- The National Cancer Institute awarded The University of Kentucky Research Foundation $281,820 on July 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to plan a future intervention trial improving clinical trial education and enrollment for cancer patients. The planning grant supports development of an intervention designed to address persistently low cancer trial enrollment rates in the United States. The award funds preparatory work for a future randomized...
- The National Cancer Institute awarded the University of Southern California $162,501 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support methodological training for social and behavioral research in cancer control. The award funds a T32 training program that will provide six predoctoral trainees per year with innovative methodological training focused on social and behavioral cancer control and prevention research. The program applies novel study design,...
- The National Cancer Institute awarded Virginia Commonwealth University $129,194 on August 11, 2026, under the Cancer Treatment Research program (CFDA 93.395) to expand participation in National Cancer Institute-sponsored clinical trials through leadership development, education, and community partnerships. Keri R. Maher, DO, Medical Director of the Clinical Trials Office at Massey Comprehensive Cancer Center within VCU, will dedicate 25 percent effort to this work. She will implement a formal...
- The National Cancer Institute awarded the University of Miami $164,190 under the Cancer Research Manpower program (CFDA 93.398) on December 17, 2025, to support biomedical training in basic, clinical, and prevention research relevant to the National Cancer Program. The project, titled "Immuno-Modulating Diffuse Midline Glioma by Epi-Transcriptomic Reprogramming," runs through September 1, 2029, with performance at the University of Miami's Office of Research Administration—School of...
- The National Cancer Institute awarded The Washington University's Office of Sponsored Research Services $403,380 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to establish the Interdisciplinary Education in Cancer Imaging and Therapy (EDUCAIT) training program. EDUCAIT trains the next generation of cancer researchers in diagnostic, prognostic, and therapeutic innovation through three tracks: molecular and functional imaging of cancer, theranostics, and predictive...
- The National Cancer Institute awarded the Regents of the University of Minnesota $309,761 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver a hands-on training course in biomarker development and applications for cancer prevention research. The course combines virtual modules on chemical carcinogenesis fundamentals with five weeks of in-person laboratory training in state-of-the-art biomarker measurement techniques at the Masonic Cancer Center....
- The National Cancer Institute awarded the University of Southern California $254,091 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support postdoctoral training in integrative cancer epidemiology. The award funds a joint training program administered by USC's Norris Comprehensive Cancer Center and the University of Hawaii Cancer Center. The program trains postdoctoral fellows for independent careers in integrative cancer epidemiology research, emphasizing...
- The National Cancer Institute awarded the University of Massachusetts Medical School $111,645 under the Cancer Research Manpower program (CFDA 93.398) on January 1, 2026, to support research training in basic and clinical cancer research. The award funds investigation of the functional role of CAMK2B loss in pancreatic cancer metastasis, examining how deletion of the calcium/calmodulin-dependent protein kinase II beta gene enhances tumor metastasis and creates an immunosuppressive tumor...
The National Cancer Institute awarded $194,909 to the University of Florida on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver the T-CAT (Trainees Communicating About Trials) Program, which trains physician trainees to communicate with patients about cancer clinical trials across the cancer continuum. The program addresses documented barriers to cancer clinical trial accrual, which remains at approximately 7–8 percent of cancer patients, with lower participation among individuals with low incomes, those from rural areas, people aged 70 years or older, and adolescents and young adults. Research demonstrates that physician communication skills education about cancer clinical trials improves patient knowledge, attitudes, comfort, and participation rates. The T-CAT Program targets an ideal intervention point by preparing trainees—who can normalize trials as a quality treatment option at referral (primary care), discuss trials during detailed oncology consultations, and activate patients to ask their oncologists about trial participation. The award funds activity at the University of Florida, Gainesville, Florida, with a performance period from September 1, 2026, through August 31, 2031. The Cancer Research Manpower program supports biomedical training opportunities for individuals interested in careers in basic, clinical, and prevention research important to the National Cancer Program, with grants made for periods up to five years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $194.9k | 8/5/26 |